SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-02-026921
Filing Date
2002-07-10
Accepted
2002-07-10 17:00:40
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a2084158zsc13ga.htm SC 13G/A 76322
3 EXHIBIT 1 a2084158zex-1.htm EX-1 13371
  Complete submission text file 0000912057-02-026921.txt   91903
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Subject) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA
Type: SC 13G/A | Act: 34 | File No.: 005-60563 | Film No.: 02700345
SIC: 2834 Pharmaceutical Preparations